Oxacyclotetracosa-3,5,9,11,17,19-hexaen-2-one,8-[[6-O-(3-carboxy-1-oxopropyl)-b-D-glucopyranosyl]oxy]-14,16-dihydroxy-24-methyl- (122540-30-1)

Identification
Name:	Oxacyclotetracosa-3,5,9,11,17,19-hexaen-2-one,8-[[6-O-(3-carboxy-1-oxopropyl)-b-D-glucopyranosyl]oxy]-14,16-dihydroxy-24-methyl-
Synonyms:	Butanedioicacid, 6'-ester with 8-(b-D-glucopyranosyloxy)-14,16-dihydroxy-24-methyloxacyclotetracosa-3,5,9,11,15,19-hexaen-2-one;Oxacyclotetracosane, butanedioic acid deriv.; Macrolactin D
CAS:	122540-30-1
Molecular Formula:	C34H48 O13
Molecular Structure:
Properties
Safety Data

Other Product

Oxacyclotetracosa-3,5,9,11,17,19-hexaen-2-one,16-(b-D-glucopyranosyloxy)-8,14-dihydroxy-24-methyl-
19-Norlanost-5-en-24-one,3-[(6-O-b-D-glucopyranosyl-b-D-glucopyranosyl)oxy]-25-(b-D-glucopyranosyloxy)-11-hydroxy-9-methyl-,(3b,9b,10a,11a)-
19-Norlanost-5-en-11-one,25-[(6-O-b-D-glucopyranosyl-b-D-glucopyranosyl)oxy]-3-(b-D-glucopyranosyloxy)-24-hydroxy-9-methyl-,(3b,9b,10a,24R)- (9CI)
1/C22H28O6/c1-23-17-11-21(27-5)19(25-3)9-15(17)13-7-8-14(13)16-10-20(26-4)22(28-6)12-18(16)24-2/h9-14H,7-8H2,1-6H3/t13-,14
19-Norlanost-5-en-11-one,3-[[2-O-(6-deoxy-a-L-mannopyranosyl)-b-D-glucopyranosyl]oxy]-25-(b-D-glucopyranosyloxy)-24-hydroxy-9-methyl-,(3b,9b,10a)- (9CI)
19-Norlanost-5-en-24-one,3-[(2-O-b-D-glucopyranosyl-b-D-glucopyranosyl)oxy]-25-(b-D-glucopyranosyloxy)-11-hydroxy-9-methyl-,(3b,9b,10a,11a)- (9CI)
Dammar-24-en-16-one,3-[(O-R-Larabinopyranosyl- â-D-glucopyranosyl)oxy]-19,- 20-dihydroxy-
b-D-Glucopyranoside, (3b,9b,10a,11a,24R)-3-[(6-O-b-D-glucopyranosyl-b-D-glucopyranosyl)oxy]-11,25-dihydroxy-9-methyl-19-norlanost-5-en-24-yl2-O-b-D-glucopyranosyl-
1/C21H26N2O4/c1-3-14-8-9-19(25)23(12-14)11-10-16-15-6-4-5-7-18(15)22-20(16)17(13-24)21(26)27-2/h4-7,12,17,22,24H,3,8-11,13H2,1-2H
1/C19H15ClN2O2S/c1-11-19(23)24-17-18(25-11)22(2)15-9-8-13(20)10-14(15)16(21-17)12-6-4-3-5-7-12/h3-11H,1-2H
Oxacyclotetracosa-3,5,9,11,17,19-hexaen-2-one,8-(b-D-glucopyranosyloxy)-14,16-dihydroxy-24-methyl-,(3Z,5E,8S,9E,11Z,14S,16R,17E,19E,24R)-
1/C14H9Br2O2P/c15-11-6-8-13(17-11)19(10-4-2-1-3-5-10)14-9-7-12(16)18-14/h1-9
1/C18H18O6/c1-22-14-8-13(20)15-16(21)11(9-24-18(15)17(14)23-2)7-10-3-5-12(19)6-4-10/h3-6,8,11,19-20H,7,9H2,1-2H
1/C26H18O2/c1-17-16-23-21-9-5-3-7-19(21)11-13-25(23)28-26(17)15-14-22-20-8-4-2-6-18(20)10-12-24(22)27-26/h2-16H,1H
19-Norlanosta-5,24-dien-11-one,26-[(6-O-b-D-glucopyranosyl-b-D-glucopyranosyl)oxy]-3-(b-D-glucopyranosyloxy)-9-methyl-,(3b,9b,10a,24E)-
19-Norlanosta-5,24-dien-11-one,26-[(6-O-b-D-glucopyranosyl-b-D-glucopyranosyl)oxy]-3-(b-D-glucopyranosyloxy)-9-methyl-,(3b,9b,10a,24Z)- (9CI)
19-Norlanosta-5,20,24-trien-11-one,3-[(6-O-b-D-glucopyranosyl-b-D-glucopyranosyl)oxy]-26-(b-D-glucopyranosyloxy)-9-methyl-,(3a,9b,10a,24E)- (9CI)
Cholesta-9(11),24-dien-23-one,6-[(O-6-deoxy-b-D-galactopyranosyl-(1®2)-O-b-D-glucopyranosyl-(1®4)-O-[6-deoxy-b-D-glucopyranosyl-(1®2)]-O-6-deoxy-b-D-glucopyranosyl-(1®3)-b-D-glucopyranosyl)oxy]-5-hydroxy-3-(sulfooxy)-, monosodium salt, (3b,5a,6a)- (9CI)
Cholesta-8(14),24-dien-23-one,3-[[O-2-(acetylamino)-2-deoxy-b-D-galactopyranosyl-(1®4)-O-[O-b-D-glucopyranosyl-(1®2)-O-b-D-xylopyranosyl-(1®6)-2-(acetylamino)-2-deoxy-b-D-glucopyranosyl-(1®2)]-b-D-xylopyranosyl]oxy]-5,12-dihydroxy-4,4-dimethyl-, (3b,5a,12b)- (9CI)
9,19-Cyclolanostan-24-one,16-(a-L-arabinopyranosyloxy)-3-[(O-b-D-glucopyranosyl-(1®3)-O-6-deoxy-a-L-mannopyranosyl-(1®2)-b-D-glucopyranosyl)oxy]-11-hydroxy-, (3b,11a,16b)- (9CI)